Paper Details

  1. Home
  2. Paper Details

Zidovudine treatment of AIDS and ARC in Denmark 1987.

Author: BonnevieO, BuhlM, MathiesenL R, NielsenC, NielsenL, PedersenC, SøebergB, TeglbjaergL L, ThorsenB, VestergaardB F

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Zidovudine treatment in 138 patients with AIDS and ARC showed a significantly lower mortality rate compared to historical controls. The treatment was generally well-tolerated, with manageable side effects.
Paper Details　
Original Abstract of the Article :
In 1987, a total of 138 Danish patients (94 AIDS and 44 ARC) received treatment with zidovudine, a total observation period of 572 treatment months. 15 AIDS and 1 ARC patient died after a median of 70 days (range 2-295). In the ARC group 4 patients developed AIDS (3 Pneumocystis carinii pneumonia, 1...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3109/00365548909167439

データ提供：米国国立医学図書館（NLM）

Zidovudine: A Milestone in the Fight Against HIV

This research takes us back to the early days of HIV/AIDS research, a period marked by both urgency and uncertainty, much like a sandstorm approaching an oasis. The study focuses on zidovudine, a groundbreaking drug that offered hope to patients living with HIV. This study used [research methods] to explore the [main objective]. The researchers found [major findings] and discussed the implications of these findings for the [research field]. It's remarkable that [results and significance].

Zidovudine's Impact on HIV Treatment

This research highlights the transformative impact of zidovudine on HIV treatment. These findings suggest that [social significance]. While zidovudine is not a cure for HIV, it has significantly improved the lives of millions of people living with the virus. It's a testament to the power of scientific innovation in the face of adversity.

Living with HIV: Finding Your Oasis

This research reminds us that living with HIV is not a sentence. [health benefits or risks] It's essential to stay informed, work with your doctor, and access the resources you need. Remember, even in the vast desert of HIV/AIDS, there is always hope for a better future.

Dr. Camel's Conclusion

This research is a beacon of hope in the history of HIV/AIDS treatment. It marks a pivotal moment when scientists made a breakthrough that changed the lives of countless people. Zidovudine's legacy continues to inspire ongoing research and development of new and innovative therapies. Even in the face of challenges, humanity's ingenuity shines through.
Date :
  1. Date Completed 1989-12-22
  2. Date Revised 2019-08-24
Further Info :

Pubmed ID

2685984

DOI: Digital Object Identifier

10.3109/00365548909167439

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.